Thromoboangitis Obliterans / Buerger’s Disease

Non-atherosclerotic, segmental, inflammatory occlusive vascular disease affecting small and medium-sized arteries and veins, primarily of the extremities

Aetiology

Primary Association

Tobacco use (almost universal)
  • Cigarettes
  • Chewing tobacco
Other Contributing Factors
  • Genetic susceptibility
  • Endothelial dysfunction
  • Possible autoimmune component
Typical Patient Profile
  • Male (increasingly also females)
  • Age <45 years
  • Heavy smoker

Pathophysiology

Trigger: Tobacco-Induced Vascular Injury
Endothelial Dysfunction
Tobacco exposure causes:
  • Direct endothelial toxicity
  • ↓ Nitric oxide (vasodilator)
  • ↑ Endothelin (vasoconstrictor)
→ Net effect: vasoconstriction + prothrombotic state
Immune Activation
  • Tobacco alters vascular antigens → autoimmune-like response
  • Activation of:
    • T lymphocytes
    • Neutrophils
Inflammatory Cascade
Panvascular Inflammation
  • Involves:
    • Arteries
    • Veins
    • Nerves
This “neurovascular bundle involvement” is a hallmark of TAO
Cellular Infiltration
  • Neutrophils dominate early phase
  • Formation of:
    • Microabscesses within thrombus
Thrombus Formation (Central Pathology)
Highly Cellular Thrombus
  • Composed of:
    • Platelets
    • Neutrophils
    • Inflammatory cells
Unique Feature
  • Thrombus organizes but vessel wall remains relatively preserved
    • Unlike:
      • Atherosclerosis → intimal thickening
      • Vasculitis → wall destruction
Progressive Occlusion
  • Thrombus → lumen narrowing → complete occlusion
notion image
Collateral Circulation Development
Chronic Ischemia Stimulus
  • Hypoxia → angiogenic signaling
Formation of “Corkscrew Collaterals”
  • Tortuous, small vessels bypass occlusions
  • Seen on angiography (diagnostic hallmark)
notion image

Epidemiology

  • Overall rare disease
  • Prevalence varies widely by region:
    • Higher in Asia, Middle East, and Eastern Europe
    • Lower in Western Europe and North America
  • Peak incidence: 20–45 years

Risk Factors

Modifiable
  • Smoking
  • Diabetes mellitus
  • Hypertension
  • Dyslipidemia
  • Obesity
  • Sedentary lifestyle
Non-Modifiable
  • Age
  • Male sex
  • Family history
 

Clinical presentation

The hallmark of thromboangiitis obliterans (TAO) is distal ischemia in a young smoker, involving:
  • Upper and lower limbs
  • Small and medium vessels
Symptom Progression (Important for Differentials)
Stage 1: Intermittent Claudication
  • Pain in:
    • Feet (arch claudication)
    • Calves
    • Hands/forearms (very characteristic)
  • Triggered by activity
  • Relieved by rest
Stage 3: Tissue Loss
  • Painful ischemic ulcers
  • Progression to gangrene
  • Often affects:
    • Toes
    • Fingers
 
Stage 2: Rest Pain
  • Persistent ischemic pain
  • Worse at night
  • Relieved by:
    • Dangling the limb (gravity improves perfusion)
 
Symptomatology
Distal Limb Ischemia
Pain Characetristics
  • Painful ischemic ulcers
  • Progression to gangrene
  • Often affects:
    • Toes
    • Fingers
Raynaud Phenomenon
Triphasic Color Change
  1. White (ischemia)
  1. Blue (deoxygenation)
  1. Red (reperfusion)
  • Triggered by:
    • Cold
    • Stress
    • notion image
Ischemic Ulcers
Characteristics
  • Painful
  • Located at:
    • Fingertips
    • Toe tips
  • Poor healing due to poor perfusion
notion image
Upper Limb Involvement
  • Claudication in:
    • Hands
    • Forearms
  • Rare in atherosclerotic disease → strong clue for TAO
 
Superficial Thrombophlebitis
Features
  • Migratory
  • Tender nodules along superficial veins
  • Recurrent episodes
Highly suggestive of TAO when combined with ischemia
notion image
Gangrene
  • Dry gangrene common
  • May progress to:
    • Auto-amputation
    • Surgical amputation
    •  
Physical Examination Findings
Inspection
  • Pale or cyanotic digits
  • Shiny, thin skin
  • Hair loss
  • Muscle wasting (chronic disease)
Special Tests
1. Buerger’s Test
  • Elevation → pallor
  • Dependency → reactive hyperemia (rubor)
2. Allen Test
  • Assesses hand arterial supply (may be abnormal)
Palpation
  • Reduced or absent distal pulses
  • Cool extremities
Buerger’s Test / Buerger Sign
Buerger’s Test / Buerger Sign
Allen Test
Allen Test

Investigations

There is no single definitive test for thromboangiitis obliterans (TAO).
Diagnosis is clinical + exclusion of other causes of limb ischemia, especially:
  • Peripheral Arterial Disease
  • Vasculitis
  • Embolic disease
Laboratory Investigations (Exclusion-Based)
Routine Blood Tests
  • CBC → anemia, infection
  • ESR / CRP → usually normal or mildly elevated
  • Fasting glucose / HbA1c → exclude diabetes
  • Lipid profile → usually normal (non-atherosclerotic disease)
Autoimmune / Vasculitis Screening
Used to rule out systemic vasculitis:
  • ANA
  • Rheumatoid factor
  • ANCA
Coagulation Profile
  • To exclude hypercoagulable state
 
Non-Invasive Vascular Assessment
Doppler Ultrasound
Findings
  • Reduced or absent distal blood flow
  • Segmental occlusion
Utility
  • First-line imaging
  • Non-invasive and widely available
Ankle-Brachial Index (ABI)
Limitation in TAO
  • May be normal or mildly reduced
  • Because:
    • Disease is distal (below ankle vessels)
Important distinction from atherosclerotic PAD, where ABI is often markedly reduced
Imaging
Conventional Angiography (Gold Standard)
Typical Findings
  1. Segmental occlusion of small/medium arteries
  1. Distal vessel involvement (tibial, radial, ulnar)
  1. “Corkscrew collaterals” (pathognomonic)
  1. Absence of:
      • Atherosclerotic plaques
      • Calcification
notion image
 

Management

Core Principle
Absolute tobacco cessation = definitive and most important treatment
  • Complete cessation (all forms: cigarettes, chewing tobacco, even nicotine replacement may perpetuate disease)
  • Stops progression and reduces amputation risk
General Measures
  • Limb protection (avoid trauma, cold exposure)
  • Proper wound care for ulcers
  • Pain control
Pharmacotherapy
Calcium Channel Blockers
  • Vasodilators → Reduced vasospasm in Raynaud Phenomenon
  • Nifedipine, Amlodipine
Prostaglandin Analogs
  • Potent vasodilators, Inhibit thromobocyte aggregation and cell proliferation
  • Epoprostenol, Iloprost
Analgesics
  • Reduce ischemic pain
Interventional Options
Sympathectomy
  • Reduces vasospasm
  • May relieve pain
Revascularization
  • Usually not feasible (distal, segmental disease)
C. Amputation
  • For:
    • Non-healing ulcers
    • Gangrene